Limoneira CO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Limoneira CO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	112	121	129	171	165	166	185	180	192	160
Cost of revenue	83.6	91.2	98.1	152	157	148	161	169	165	155
Gross profit	28.2	30.1	31.3	19	7.28	17.5	24	10.7	26.7	4.91
Selling, general and administrative	13.3	13.9	16.1	21.2	21.3	19.4	21.8	26.5	27.5	24.5
Operating income	9.19	11.9	9.49	-5.51	-19	-6.33	2.2	10.8	-6.18	-20.4
Interest expense	1.41	1.78	1.32	2.34	2.05	1.5
Interest income	0.02		0.2	0.21	0.36	0.38	0.05	0.36	0.12	0.06
Other non-operating income	4.14	-1.24	4	-1.05	-7.43	2.17	-1.85	2.58	17.7	-0.6
Pre-tax income	13.3	10.6	13.5	-6.56	-26.4	-4.16	0.35	13.4	11.5	-21
Income tax	5.27	4.08	-6.73	-1.1	-8.49	-0.27	0.82	4.25	4.37	-4.65
Net income to minority interests	0	-0.05	0.02	0.48	-1.51	-0.46	-0.24	-0.28	-0.54	-0.38
Net income	8.06	6.6	20.2	-5.94	-16.4	-3.44	-0.24	9.4	7.72	-16
EBITDA	14.5	18.3	16.8	3.12	-8.91	3.48	12	19.4	2.2	-11.2
EPS, basic	0.52	0.42	1.26	-0.37	-0.96	-0.23	-0.04	0.50	0.40	-0.93
EPS, diluted	0.52	0.42	1.25	-0.37	-0.96	-0.23	-0.04	0.50	0.40	-0.93
Shares, basic (weighted)	14.2	14.3	15.6	17.6	17.7	17.6	17.5	17.6	17.7	17.8
Shares, diluted (weighted)	14.2	14.3	16.2	17.6	17.7	17.6	17.5	17.6	17.7	17.8
Dividend per share	0.20	0.22	0.25	0.30	0.30	0.30	0.30	0.30	0.30	0.30

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.04	0.49	0.61	0.62	0.5	0.44	0.86	3.63	3	1.51
Receivables	9.3	11	14.1	15.1	16.3	17.5	15.7	14.5	14.7	15.4
Other current assets	2.51	6.98	10.5	8.15	10.7	10.7	8.5	5.59	3.85	4.44
Total current assets	18.5	23.1	31	35.1	42.5	42.1	37.5	30.2	25.8	40.5
Property, plant and equipment	177	188	226	248	243	242	223	161	162	173
Lease right-of-use assets					2.05	2.04	6.19	3.48	2.42	0.64
Goodwill	0.68	0.88	1.43	1.84	1.54	1.53	1.51	1.51	1.5	1.51
Intangible assets	0.1	0.08	6.23	12.4	11.3	8.33	7.32	6.66	5.22	2.62
Other non-current assets	8.72	10.4	6.85	9.27	8.74	11	17	13.4	12.5	11.1
Total assets	305	339	421	400	390	392	369	301	299	311
Accounts payable	5.56	6.31	6.13	4.97	5.84	8.96	10.7	9.89	7.26	7.9
Accrued liabilities	6.42	5.18	7.72	8.26	7.95	6.54	11.3	8.65	12.5	9.29
Deferred revenue	0.63	0.64	0.5
Short-term debt	2.51	3.03	3.13	3.02	3.28	2.47	1.73	0.38	0.56	0.03
Total current liabilities	23.8	23.6	27.1	31.7	31.5	35.3	39.3	33.4	34.8	30.1
Long-term debt	88.2	102	77	106	123	130	104	40.6	40	72.5
Lease liabilities					1.61	1.65	4.35	1.71	0.4	0.22
Other non-current liabilities	6.13	3.92	3.65	5.47	6.57	4.5	9.81	4.56	1.4	2.38
Total liabilities	167	191	191	167	183	193	177	101	96.3	120
Total debt	90.7	105	80.1	109	126	133	106	41	40.6	72.5
Paid-in capital	91.8	94.3	159	160	162	164	165	168	170	171
Retained earnings	31.8	34.7	50.4	53.1	30.8	21.6	15.5	19	20.8	-1.07
Treasury stock				0	-3.49	-3.49	-3.49	-3.49	-3.49	-3.49
Other comprehensive income	2.7	7.08	8.97	-7.26	-7.55	-5.73	-7.91	-5.67	-6.61	-6.27
Shareholders' equity	126	137	219
Minority interests	0	0.59	0.57	15.4	13.7	12	11.6	11.2	10.5	19.3
Total equity	126	137	219	222	196	188	181	190	192	180
Total liabilities and equity	305	339	421	400	390	392	369	301	299	311
Shares outstanding	14.2	14.4	17.6	17.8	17.6	17.7	17.7	17.9	18	18

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	8.06	6.55	20.2	-5.47	-17.9	-3.9	-0.47	9.12	7.17	-16.4
Depreciation and amortization	5.34	6.47	7.28	8.63	10.1	9.81	9.8	8.58	8.37	9.21
Stock-based compensation	1.31	1.33	1.37	1.79	2.04	2.58	2.73	3.84	4.12	3.08
Deferred income tax	6.2	2.29	-7.31	-0.77	-2.13	-0.19	0.55	-1.95	-2.09	-4.71
Change in receivables	-1.88	-1.56	-3.24	-4.01	-0.31	-5.08	1.85	0.82	1.11	0.47
Change in inventory	0.07	0.19	-0.75	1.45	0.36	-0.64	-1.15	2.46	0.45	-0.53
Change in payables	0.81	0.47	0.71	3.39	-5.55	5.39	1.85	-1.77	-3.34	-1.72
Cash from operations	14.3	18.5	18.4	1.37	-11.3	9.61	14.8	-15.9	17.9	-6.01
Capital expenditures	-16.3	-12.9	-13.9	-15.9
Acquisitions	0	-5.71	-25	-15	0	0
Sales and maturities of investments	4.02	0	4.72	4.79	11	0	0
Cash from investing	-11.5	-26.4	-50.8	-23.7	3.85	-10.2	19.4	90.6	-9.19	-18.3
Debt issued	157	181	167	123	121	102	147	57.9	176	170
Debt repaid	-156	-169	-194	-94	-104	-95.1	-174	-123	-176	-138
Stock issued	0	0	64.1	0	0
Share buybacks			0	0	-3.49	0	0
Dividends paid	-2.83	-3.16	-4.03	-5.33	-5.36	-5.3	-5.32	-5.38	-5.41	-5.41
Cash from financing	-2.78	8.38	32.5	22.4	7.36	0.53	-33.5	-71.9	-9.29	22.8
Exchange rate effect	0	0.01	-0.02	-0.14	-0.01	0.04	-0.33	-0.01	-0.01	0.03
Net change in cash		0.45	0.12	0.01	-0.12	-0.06	0.42	2.77	-0.64	-1.49
Free cash flow	-1.95	5.58	4.52	-14.5
Interest paid	1.41	1.64	1.59	2.53	1.87	1.5	2.06	0.65	0.97	1.19
Income taxes paid	2.13	-0.54	0.21	0.13	-1.24	-5.91	0.08	7.23	5.19	0.71

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $11.78 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	-1.7%	Gross profit / revenue.
Operating margin	-35.9%	Operating income / revenue.
EBITDA margin	-29.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-43.0%	Pre-tax income / revenue.
Net margin	-33.0%	Net income / revenue.
Operating cash flow margin	-11.6%	Cash from operations / revenue.
Return on assets (ROA)	-14.2%	Net income / average total assets.
SG&A / revenue	16.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.4%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	6.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-16.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-0.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-81.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-41.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-7.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-609.8%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-307.1%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-332.5%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-133.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	4.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-5.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-4.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.51x	Current assets / current liabilities.
Quick ratio	0.67x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.08x	(Cash + short-term investments) / current liabilities.
Debt / assets	33.9%	Total debt / total assets.
Liabilities / assets	46.2%	Total liabilities / total assets.
Net debt	$99.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$13.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	1.2%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.43x	Revenue / average total assets.
Fixed asset turnover	0.90x	Revenue / average property, plant and equipment.
Receivables turnover	8.39x	Revenue / average receivables.
Days sales outstanding	43 days	365 x average receivables / revenue.
Days payables	16 days	365 x average accounts payable / cost of revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$2.37	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$7.17	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.83	Cash from operations / diluted weighted shares.
Cash per share	$0.12	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$213.6M	Share price x shares outstanding.
Enterprise value	$312.9M	Market cap + total debt - cash - short-term investments.
P/S	1.66x	Market cap / revenue.
EV/Sales	2.43x	Enterprise value / revenue.
Earnings yield	-19.9%	Net income / market cap (the inverse of P/E).
Dividend yield	1.3%	Dividends paid over the period / market cap.
Shareholder yield	1.3%	(Dividends paid + share buybacks) / market cap.

What was Limoneira CO's revenue in fiscal 2025?

Limoneira CO reported revenue of $159.7M for fiscal 2025, 16.6% lower than the year before.

Was Limoneira CO profitable in fiscal 2025?

No. It reported a net loss of $16.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Limoneira CO